Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Safety × Plasma cell × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Plasma cell 1 Breast 1

Conditions

Multiple Myeloma 1

Interventions

Bortezomib 20 Surveys and Questionnaires 8 Blood Specimen Collection 8 Lenalidomide 7 Dexamethasone 7 daratumumab 6 Flow Cytometry 6 pomalidomide 4 plerixafor 4 idecabtagene vicleucel 4 carfilzomib 4 Standard of Care 4 Polymerase Chain Reaction 4 Immunoenzyme Techniques 4 Biopsy 4 Amplified Fragment Length Polymorphism Analysis 4 Specimen Handling 3 Psychiatric Rehabilitation 3 Microarray Analysis 3 Melphalan 3 Magnetic Resonance Spectroscopy 3 Interviews as Topic 3 Data Collection 3 Cytogenetic Analysis 3 talquetamab 2 selinexor 2 belantamab mafodotin 2 Watchful Waiting 2 Reverse Transcriptase Polymerase Chain Reaction 2 Proteasome Inhibitors 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02786511 2020-01-22

Longterm Follow-up of Subjects Treated With bb2121

Celgene

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡